Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Cash from Discontinued Operations (2021 - 2024)

Historic Cash from Discontinued Operations for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to $3.4 million.

  • Trinity Biotech's Cash from Discontinued Operations rose 126734.69% to $3.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year increase of 18215.26%. This contributed to the annual value of -$4.2 million for FY2024, which is 6373.63% up from last year.
  • Trinity Biotech's Cash from Discontinued Operations amounted to $3.4 million in Q4 2024, which was up 126734.69% from $245000.0 recorded in Q4 2023.
  • In the past 5 years, Trinity Biotech's Cash from Discontinued Operations registered a high of $4.3 million during Q4 2021, and its lowest value of -$4.7 million during Q3 2023.
  • Moreover, its 4-year median value for Cash from Discontinued Operations was $1.5 million (2022), whereas its average is $1.0 million.
  • Per our database at Business Quant, Trinity Biotech's Cash from Discontinued Operations plummeted by 78994.08% in 2023 and then skyrocketed by 126734.69% in 2024.
  • Quarter analysis of 4 years shows Trinity Biotech's Cash from Discontinued Operations stood at $4.3 million in 2021, then tumbled by 47.46% to $2.3 million in 2022, then plummeted by 89.23% to $245000.0 in 2023, then surged by 1267.35% to $3.4 million in 2024.
  • Its Cash from Discontinued Operations stands at $3.4 million for Q4 2024, versus $245000.0 for Q4 2023 and -$4.7 million for Q3 2023.